Mettler-Toledo International Inc.

What they do

Mettler-Toledo designs and manufactures precision laboratory instruments—balances, pipettes, titrators, thermal analysis systems, pH meters, and process analytics sensors—along with automated chemistry solutions and LabX software. It also provides value-added services such as pipette recalibration. Products are sold in more than 140 countries with a direct presence in about 40.

Revenue drivers

• Laboratory Instruments — Includes balances, pipettes, analytical instruments, automated reactors, and LabX software; accounted for approximately 56% of net sales in 2025 and 2024.
• Process Analytics — Provides in-line measurement instruments for liquid and gas parameters; serves pharmaceutical, chemical, and other process industries.
• Geographic regions — 2025 net sales derived 42% from North and South America, 29% from Europe, and 29% from Asia and other countries.

Recent performance

In Q2 2026, reported sales rose 4% to $1.027 billion; local currency sales increased 6% excluding a one-time tariff refund. GAAP EPS was $11.55 versus $9.76 a year ago; adjusted EPS rose 14% to $11.46. Reported sales grew 7% in Europe and 12% in Asia Rest of World, but fell 3% in the Americas. For H1 2026, sales reached $1.974 billion and adjusted EPS was $20.35, up 11%.

Strategy

Management highlighted the Spinnaker sales and marketing and productivity initiatives as key drivers of growth and margin improvement. The company aims to fully offset the impact of 2025 incremental tariffs through mitigation actions implemented in 2026. It continues to invest in R&D (5.3% of sales in H1 2026) and focuses on capturing growth in China and emerging markets. The company also plans to distribute $27.8 million in tariff-related refunds to customers in Q3 2026.

Risks

• Economic downturn in developed countries — Most sales come from developed countries; recessions lead customers to delay or reduce capital expenditures on instruments.
• International operations and China concentration — Significant business in China faces reduced demand, tariffs, trade barriers, and potential retaliatory actions.
• Tariff and trade disputes — Incremental U.S. tariffs on imports from Switzerland, China, EU, and others, plus Chinese counter-tariffs, increased costs by about $50 million in 2025.
• Currency fluctuations — Greater foreign exchange rate volatility can affect profitability and cash flow given global sales and operations.

Outlook

Management expects Q3 2026 local currency sales to increase approximately 4% and adjusted EPS of $12.00 to $12.15 (8-9% growth). For full-year 2026, local currency sales are expected to rise about 4% to 5% excluding tariff refunds, and adjusted EPS is forecast at $47.15 to $47.50, up ~10-11%. Guidance was raised from prior adjusted EPS range of $46.30 to $46.95.